US Stock MarketDetailed Quotes

PTC Therapeutics (PTCT)

Watchlist
  • 71.300
  • +1.720+2.47%
Trading Apr 8 11:33 ET
5.90BMarket Cap9.16P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

PTC Therapeutics (PTCT) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
Collaboration and license revenue998.36M57.69%
Royalty revenue244.22M14.11%
Translarna235.3M13.60%
Emflaza146.36M8.46%
Sephience111.15M6.42%
Upstaza/Kebilidi56.63M3.27%
All other products37.26M2.15%
Translarna France-98.63M-5.70%
View all

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States1.49B86.37%
Non - United States (US)235.89M13.63%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.28%
Sample Name
Sample Code
 +12.62%
Sample Name
Sample Code
 +11.35%
4
United Sts Brent Oil Fd Lp Unit
BNO
+9.81%
5
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+7.04%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.12%
Sample Name
Sample Code
 +13.56%
Sample Name
Sample Code
 +13.34%
4
Kingsoft Cloud
KC
+10.74%
5
ASE Technology
ASX
+10.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
A major turning point has emerged in the US-Iran situation! Trump announced a two-week suspension of military action against Iran, and both Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -